ResearcherHokkaido UniversityActive in the last 2 years
Mitsuru Sugawara
Matched on ORCID iD 0000-0001-5350-2950; OpenAlex author ID A5081284897. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2025: 4 papers · 2026: 1 paper
Papers 5
- Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer. Last author DOI 10.1007/s00520-026-11157-0↗
- Identification of risk factors related to problematic peripheral neuropathy development in gemcitabine and nab-paclitaxel treatment for pancreatic cancer. Last author DOI 10.1007/s00520-025-09336-6↗
- Impact of baseline hypoalbuminemia on peripheral edema induced by gemcitabine and nab-paclitaxel for pancreatic cancer treatment. Last author DOI 10.1007/s00520-025-10026-6↗
- Evaluation of factors associated with drug fever following gemcitabine and nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer. Last author DOI 10.1007/s00520-025-10081-z↗
- Factors associated with taxane-associated acute pain syndrome in pancreatic cancer patients receiving gemcitabine and nab-paclitaxel. Last author DOI 10.1007/s12672-025-03796-2↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshito Komatsu · 5 shared papers, 2025–2026 · strength 1.90
- Paper Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment … DOI 10.1007/s00520-026-11157-0↗
- Paper Identification of risk factors related to problematic peripheral neuropathy development in gemcitabine and nab-paclitax… DOI 10.1007/s00520-025-09336-6↗
- Paper Impact of baseline hypoalbuminemia on peripheral edema induced by gemcitabine and nab-paclitaxel for pancreatic cancer … DOI 10.1007/s00520-025-10026-6↗
- Yoshitaka Saito · 4 shared papers, 2025–2026 · strength 1.53
- Paper Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment … DOI 10.1007/s00520-026-11157-0↗
- Paper Identification of risk factors related to problematic peripheral neuropathy development in gemcitabine and nab-paclitax… DOI 10.1007/s00520-025-09336-6↗
- Paper Impact of baseline hypoalbuminemia on peripheral edema induced by gemcitabine and nab-paclitaxel for pancreatic cancer … DOI 10.1007/s00520-025-10026-6↗
- Yoshitaka Saito · 1 shared paper, 2025 · strength 0.37
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.